An Observational Study to Evaluate the Changes in Prostate Volume Over Time With The Use of Transrectal Ultrasound and Computed Tomography Following Permanent Prostate Brachytherapy With Iodine-125 Seeds.
N/A
18 Years
80 Years
18 Years
80 Years
Not Enrolling
Male
Prostate Cancer
Male
Prostate Cancer
Trial Information
An Observational Study to Evaluate the Changes in Prostate Volume Over Time With The Use of Transrectal Ultrasound and Computed Tomography Following Permanent Prostate Brachytherapy With Iodine-125 Seeds.
The prostate size will be measured using the TRUS and CT scan on days -1, 0, 1, 9, 30, and
60 days after the brachytherapy procedure.
Inclusion Criteria:
- Pathologically confirmed diagnosis of prostate cancer
- T1-3 disease
- PSA <20 ng/ml
- Patient must sign a study-specific informed consent prior to enrollment.
Exclusion Criteria:
- Patients ineligible to brachytherapy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Hani Ashamalla, MD, FCCP
Investigator Role:
Study Chair
Investigator Affiliation:
New York Methodist Hospital
Authority:
United States: Institutional Review Board
Study ID:
NYM-353
NCT ID:
NCT00348465
Start Date:
May 2006
Completion Date:
March 2008
Related Keywords:
- Prostate Cancer
- Brachytherapy
- Prostate volume
- Prostatic Neoplasms
Name | Location |
|---|
